StimLabs rolls out new allograft product Enverse for wound care
Enverse is a translucent dehydrated complete human placental membrane (dCHPM) allograft product, processed using StimLabs’ patented Clearify method…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
04 Jul 22
Enverse is a translucent dehydrated complete human placental membrane (dCHPM) allograft product, processed using StimLabs’ patented Clearify method…
07 Apr 22
Aatru Medical plans to introduce the FDA 510(k) cleared product in Latin America and the US, followed by…
15 Mar 22
Strategic Alliance Positioned to Grow Sales Opportunities in Non-Government Hospital Channel
28 Feb 22
Swift Medical will unveil a first-of-its-kind technology that will allow patients to access hospital quality care from anywhere…
24 Feb 22
Gunze developed its absorbable adhesion barrier by applying proprietary absorbable material technology
15 Feb 22
The new PalinGen membrane products are designed to treat patients with non-healing acute and chronic wounds, as well…
31 Jan 22
Triad, which develops biologically-derived innovative products for surgical wounds, chronic wounds and burns, is expected to benefit from…
25 Jan 22
As part of the process for FDA clearance of the PICO 7 and 14 sNPWT Systems, the clinical…
10 Dec 21
The acquisition will add Tissuemed’s surgical sealant to BD's suite of biosurgery products already relied upon in the…
19 Oct 21
Biomodex to debut Thrombotech™ at CNS 2021 Annual Meeting in Austin, TX